1979
DOI: 10.1038/279072a0
|View full text |Cite
|
Sign up to set email alerts
|

Solubilisation of high-affinity dopamine receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
10
0

Year Published

1983
1983
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(12 citation statements)
references
References 22 publications
2
10
0
Order By: Relevance
“…almost three times higher than the corresponding value for membrane-bound receptors which was 1.25 ± 0.10nM. Similar effect was observed by several authors working on receptor solubilization (Gorissen et al, 1979;Madras et al, 1982;Davis et al, 1982;Witkin & Harden, 1982;Kuno et al, 1983) and it very probably results from the change in chemical environment of the receptor molecule.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…almost three times higher than the corresponding value for membrane-bound receptors which was 1.25 ± 0.10nM. Similar effect was observed by several authors working on receptor solubilization (Gorissen et al, 1979;Madras et al, 1982;Davis et al, 1982;Witkin & Harden, 1982;Kuno et al, 1983) and it very probably results from the change in chemical environment of the receptor molecule.…”
Section: Discussionsupporting
confidence: 79%
“…Dopamine receptors were isolated from several sources and solubilization was achieved with different detergents (Laduron & Ilien, 1982;Hall et al, 1983;Kuno et al, 1983). Using plant glycoside digitonin, Gorissen & Laduron (1979) reported the solubilization of binding sites from dog striatum which retained the characteristics of membranebound dopamine receptors. Gorissen et al (1980) showed that digitonin-solubilized dopamine receptors from rat striatum are masked by a high number of non-stereospecific spirodecanone sites, the number of which was much higher in the frontal cortex than in the striatum.…”
Section: Introductionmentioning
confidence: 99%
“…5d). The role of dopaminergic D1-like receptors in exercise was also confirmed in vivo by using butaclamol, a well-characterized D1-receptor antagonist (Denef et al, 1980; Gorissen and Laduron, 1979). Administration of butaclamol before the exercise prevented the potential of exercise to attenuate serum TNF levels in endotoxemia (Fig.…”
Section: Resultsmentioning
confidence: 88%
“…Given that dopamine signals through either D1-like (D1R, D5R) or D2-like (D2R, D3R, D4R) dopaminergic receptors, we analyzed specific dopaminergic agonists including fenoldopam (a highly selective agonist for D1-like receptors) and pergolide (a selective agonist for D2-like receptors) (Gingrich and Caron, 1993; Grenader and Healy, 1991; Weber et al, 1998). Fenoldopam and pergolide are well-characterized stable and specific dopaminergic agonist with about 100-fold greater affinity for D1-like or D2-like receptors, respectively (Denef et al, 1980; Gorissen and Laduron, 1979; Grenader and Healy, 1991; Tiberi and Caron, 1994; Torres-Rosas et al, 2014; Weber et al, 1998). Fenoldopam was more effective than dopamine and pergolide at inhibiting LPS-induced TNF production in primary culture of splenocytes (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Fenoldopam was more efficient than dopamine and pergolide at inhibiting LPS-induced TNF production both ex vivo and in vivo (Fig.4a,b). The role of D1-receptors was confirmed by using butaclamol, a standard D1-receptor antagonist 32,33 that inhibited the anti-inflammatory effects of electroacupuncture (Fig.4c,d; Supplementary Fig.3c). One dose of fenoldopam right after the induction of sepsis prevented mortality in polymicrobial peritonitis (Supplementary Fig.3d), and inhibited serum HMGB1 levels (Fig.4e).…”
mentioning
confidence: 79%